Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.99 CHF | -0.87% | -1.72% | +18.22% |
08/05 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
08/05 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.22% | 1.53TCr | |
+21.59% | 4.42TCr | |
+23.03% | 2.3TCr | |
+12.26% | 1.37TCr | |
+52.55% | 1.22TCr | |
-10.02% | 683.92Cr | |
-0.05% | 678.76Cr | |
-8.87% | 572.55Cr | |
+12.92% | 565.87Cr | |
+6.11% | 484.98Cr |
- Stock Market
- Equities
- SDZ Stock
- News Sandoz Group AG
- Transcript : Sandoz Group AG, Q4 2023 Earnings Call, Mar 13, 2024